Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Dronabinol Metered Dose Inhaler (MDI) in Acute Treatment of Migraine Headache [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of dronabinol delivered via metered-dose inhaler for acute treatment of migraine headaches has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine Without Aura
• Migraine with Aura

Drugs mentioned

• Dronabinol (dronabinol)

Snippet

Sponsor: Solvay Pharmaceuticals | Conditions: Migraine With Aura, Migraine Without Aura | Phase 2 | Status: COMPLETED